Kelley Shannon T (CIK 2034056) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-06). Recent activity: Sell MDGL (360 shares), Buy MDGL (4,017 shares), Sell MDGL (263 shares), Sell MDGL (429 shares), Sell MDGL (458 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-06 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Sell | 360 | $155,498 |
| 2026-03-06 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Buy | 4,017 | $0 |
| 2026-01-20 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Sell | 263 | $129,073 |
| 2026-01-20 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Sell | 429 | $215,101 |
| 2025-08-18 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Sell | 458 | $164,266 |
| 2025-08-18 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Sell | 126 | $46,575 |
| 2025-08-18 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Sell | 84 | $31,085 |
| 2025-08-18 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Sell | 84 | $31,193 |
| 2025-08-18 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Sell | 252 | $93,855 |
| 2025-08-18 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Sell | 68 | $25,441 |
| 2025-08-18 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Sell | 190 | $71,392 |
| 2025-08-18 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Sell | 42 | $15,818 |
| 2025-03-07 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Buy | 3,187 | $0 |
| 2025-03-05 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Sell | 415 | $139,025 |
| 2025-01-17 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | General Counsel | Sell | 277 | $75,735 |
Source: SEC Form 4 filings · as of 2026-03-06